Differential actions of antidepressant treatments on cardiac autonomic alterations in depression: A prospective comparison

Asian Journal of Psychiatry

Volumn 4, Issue 2, 2011, Pages 100-106

  Udupa, Kaviraja ^a   Thirthalli, Jagadisha ^a   Sathyaprabha, T N ^a   Kishore, K R ^a   Raju, T R ^a   Gangadhar, B N ^a  

^a NATIONAL INSTITUTE OF MENTAL HEALTH AND NEUROSCIENCES   (India)

Author keywords

Cardiac autonomic functions; Heart rate variability; Repetitive transcranial magnetic stimulation; Selective serotonin re uptake inhibitors; Tricyclic antidepressants

Indexed keywords

AMITRIPTYLINE; ESCITALOPRAM; IMIPRAMINE; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; TRICYCLIC ANTIDEPRESSANT AGENT;

ADULT; AGE; ARTICLE; AUTONOMIC NERVOUS SYSTEM FUNCTION; BEDTIME DOSAGE; BREATHING; CLINICAL TRIAL; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DISEASE SEVERITY; DRUG EFFECT; FEMALE; FUNCTION TEST; HAMILTON SCALE; HEART RATE; HEART RATE VARIABILITY; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; MENTAL PATIENT; MONTGOMERY ASBERG DEPRESSION RATING SCALE; PRIORITY JOURNAL; PROSPECTIVE STUDY; PSYCHOPHARMACOTHERAPY; SEX DIFFERENCE; SYMPATHOVAGAL BALANCE; SYSTOLIC BLOOD PRESSURE; TRANSCRANIAL MAGNETIC STIMULATION; VALSALVA MANEUVER;

EID: 79958717204     PISSN: 18762018     EISSN: 18762026     Source Type: Journal    
DOI: 10.1016/j.ajp.2011.02.006     Document Type: Article

References (30)

1. American Psychiatric Association (APA) Diagnostic and Statistical Manual of Mental Disorders 2000, Jaypee brothers' medical publishers (P) Ltd., New Delhi, 369-376. Fourth Edition.
2. Balogh S., Fitzpatrick D.F., Hendricks S.E., Paige S.R. Increases in heart rate variability with successful treatment in patients with major depressive disorder. Psychopharmacol. Bull. 1993, 29(2):201-206.
3. Ben Shachar D., Belmaker R.H., Grisaru N., Klein E. Transcranial magnetic stimulation induces alterations in brain monoamines. J. Neural Transm. 1997, 104(2-3):191-197.
4. Bigger J.T., Fleiss J.L., Rolnitzky L.M., Steinman R.C., Schneider W.J. Time course of recovery of heart period variability after myocardial infarction. J. Am. Coll. Cardiol. 1991, 18(7):1643-1649.
5. Burrows G.D., Vohra J., Hunt D., Sloman J.G., Scoggins B.A., Davies B. Cardiac effects of different tricyclic antidepressant drugs. Br. J. Psychiatry 1976, 129(October):335-341.
6. Carney R.M., Freedland K.E., Stein P.K., Skala J.A., Hoffman P., Jaffe A.S. Change in heart rate and heart rate variability during treatment for depression in patients with coronary heart disease. Psychosom. Med. 2000, 62(5):639-647.
7. Cohen J. Statistical Power Analysis for the Behavioral Sciences 1988, Lawrence Erlbaum Associates, Hillsdale, New Jersey, [stat/mult_pkg/sas/footer.htm].
8. George M.S., Wassermann E.M., Williams W.A., Callahan A., Ketter T.A., Basser P., Hallett M., Post R.M. Daily repetitive transcranial magnetic stimulation (rTMS) improves mood in depression. Neuroreport 1995, 6(14):1853-1856.
9. Glassman A.H., Stetner F., Walsh B.T., Raizman P.S., Fleiss J.L., Cooper T.B., Covey L.S. Heavy smokers, smoking cessation, and clonidine. results of a double-blind, randomized trial. JAMA 1988, 259(19):2863-2866.
10. Hamilton M. Development of a rating scale for primary depressive illness. Br. J. Soc. Clin. Psychol. 1967, 6(4):278-296.
11. Jackson W.K., Roose S.P., Glassman A.H. Cardiovascular toxicity and tricyclic antidepressants. Biomed. Pharmacother. 1987, 41(7):377-382.
12. Ji R.R., Schlaepfer T.E., Aizenman C.D., Epstein C.M., Qiu D., Huang J.C., Rupp F. Repetitive transcranial magnetic stimulation activates specific regions in rat brain. Proc. Natl. Acad. Sci. U.S.A. 1998, 95(26):15635-15640.
13. Kemp A.H., Quintana D.S., Gray M.A., Felmingham K.L., Brown K., Gatt J. Impact of depression and antidepressant treatment on heart rate variability: a review and meta-analysis. Biol Psychiatry 2010, [Epub ahead of print, PMID: 20138254].
14. Khaykin Y., Dorian P., Baker B., Shapiro C., Sandor P., Mironov D., Irvine J., Newman D. Autonomic correlates of antidepressant treatment using heart-rate variability analysis. Can. J. Psychiatry 1998, 43(2):183-186.
15. Licht C.M., de Geus E.J., Zitman F.G., Hoogendijk W.J., van Dyck R., Penninx B.W. Association between major depressive disorder and heart rate variability in the Netherlands Study of Depression and Anxiety (NESDA). Arch. Gen. Psychiatry 2008, 65(12):1358-1367.
16. Montgomery S.A., Asberg M. A new depression scale designed to be sensitive to change. Br. J. Psychiatry 1979, 134(April):382-389.
17. Pascual-Leone A., Rubio B., Pallardo F., Catala M.D. Rapid-rate transcranial magnetic stimulation of left dorsolateral prefrontal cortex in drug-resistant depression. Lancet 1996, 348(9022):233-237.
18. Penninx B.W., Beekman A.T., Honig A., Deeg D.J., Schoevers R.A., van Eijk J.T., van Tilburg W. Depression and cardiac mortality: results from a community-based longitudinal study. Arch. Gen. Psychiatry 2001, 58(3):221-227.
19. Prasad M.K., Udupa K., Kishore K.R., Thirthalli J., Sathyaprabha T.N., Gangadhar B.N. Inter-rater reliability of Hamilton depression rating scale using video- recorded interviews - focus on rater-blinding. Indian J. Psychiatry 2009, 51(3):191-194.
20. Rechlin T., Claus D., Weis M. Heart rate analysis in 24 patients treated with 150mg amitriptyline per day. Psychopharmacology (Berlin) 1994, 116(1):110-114.
21. Rottenberg J. Cardiac vagal control in depression: a critical analysis. Biol. Psychol. 2007, 74(2):200-211.
22. Sathyaprabha T.N., Satishchandra P., Netravathi K., Sinha S., Thennarasu K., Raju T.R. Cardiac autonomic dysfunctions in chronic refractory epilepsy. Epilepsy Res. 2006, 72(1):49-56.
23. Task force of the European society of cardiology and the North American society of pacing and electro physiology Heart rate variability, Standards of measurement, physiological interpretation, and clinical use. Circulation 1996, 93(5):1043-1065.
24. Tulen J.H., Bruijn J.A., de Man K.J., Pepplinkhuizen L., van den Meiracker A.H., Man in't Veld A.J. Cardiovascular variability in major depressive disorder and effects of imipramine or mirtazapine (Org 3770). J. Clin. Psychopharmacol. 1996, 16(2):135-145.
25. Udupa K., Sathyaprabha T.N., Thirthalli J., Kishore K.R., Lavekar G.S., Raju T.R., Gangadhar B.N. Alteration of cardiac autonomic functions in patients with major depression: a study using heart rate variability measures. J. Affect. Disord. 2007, 100(1-3):137-141.
26. Udupa K., Sathyaprabha T.N., Thirthalli J., Kishore K.R., Raju T.R., Gangadhar B.N. Modulation of cardiac autonomic functions in patients with major depression treated with repetitive transcranial magnetic stimulation. J. Affect. Disord. 2007, 104(1-3):231-236.
27. van Zyl L.T., Hasegawa T., Nagata K. Effects of antidepressant treatment on heart rate variability in major depression: a quantitative review. Biopsychosoc. Med. 2008, 2:12. 10.1186/1751-0759-2-12.
28. Vohra J., Burrows G., Hunt D., Sloman G. The effect of toxic and therapeutic doses of tricyclic antidepressant drugs on intracardiac conduction. Eur. J. Cardiol. 1975, 3(3):219-227.
29. Volkers A.C., Tulen J.H., van den Broek W.W., Bruyn J.A., Passchier J., Pepplinkhuizen L. Effects of imipramine, fluvoxamine and depressive mood on autonomic cardiac functioning in major depressive disorder. Pharmacopsychiatry 2004, 37(1):18-25.
30. Wassermann E.M. Risk and safety of repetitive transcranial magnetic stimulation: report and suggested guidelines from the International Workshop on the Safety of Repetitive Transcranial Magnetic Stimulation, June 5-7, 1996. Electroencephalogr. Clin. Neurophysiol. 1998, 108(1):1-16.